Integrating advances in facility design can meet differing and emerging bioprocessing needs.
Switching grades of raw material late in the development cycle can be costly. Best practice says get it right at the beginning.
Unexpected problems can become opportunities to share knowledge and improve processes.
Defining best biopharmaceutical practices is necessary to ensure the safety of the supply chain.